Spiriva (2013-10-07)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 107625 | Spiriva | - Recalling Firm
- Boehringer Ingelheim (Canada) Ltd.
- 5180 South Service Road
- Burlington
- L7L 5H4
- Ontario
- CANADA
- Marketing Authorization Holder
- Boehringer Ingelheim (Canada) Ltd.
- 5180 South Service Road
- Burlington
- L7L 5H4
- Ontario
- CANADA
| Capsule | DIN 02246793 | 18 μg tiotropium (22.5 μg tiotropium bromide monohydrate) per capsule |
Recalled Products
Spiriva
Drug substance material used to make drug product lots may be contaminated with extrinsic foreign particles.
Wholesalers across Canada